H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| ElevateBio Technologies Inc. | 2 | $115,000 | $105,000 - $125,000 | 100.0% |
| ModernaTX, Inc. | 2 | $115,000 | $104,500 - $125,500 | 100.0% |
| CRISPR Therapeutics, Inc. | 1 | $125,000 | $125,000 - $125,000 | 100.0% |
| Dicerna Pharmaceuticals, Inc. | 1 | $120,000 | $120,000 - $120,000 | 0.0% |
| Sumitomo Pharma Oncology | 1 | $109,408 | $109,408 - $109,408 | 100.0% |
| Zeno Management, Inc. | 1 | $125,000 | $125,000 - $125,000 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| I | 4 | $114,704 | $105,000 - $125,000 |
| Senior | 2 | $125,250 | $125,000 - $125,500 |
| Unspecified | 1 | $104,500 | $104,500 - $104,500 |
| II | 1 | $125,000 | $125,000 - $125,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Cambridge | MA | 2 | $115,000 |
| Durham | NC | 2 | $115,000 |
| Boston | MA | 1 | $125,000 |
| Lexington | MA | 1 | $120,000 |
| San Diego | CA | 1 | $125,000 |
| Suite 100 | UT | 1 | $109,408 |
These roles are variations of SCIENTIST, TRANSLATIONAL BIOLOGY with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Scientist I, Translational Biology | 4 | $114,852 | |
| SCIENTIST, TRANSLATIONAL BIOLOGY | Unspecified | 3 | $108,327 |
| Senior Scientist, Translational Biology | 2 | $125,250 | |
| Scientist II, Translational Biology (00100808) | 1 | $125,000 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2023 | 1 | $109,408 | 100.0% |
| 2024 | 2 | $114,750 | 100.0% |
| 2025 | 2 | $122,750 | 50.0% |
| 2026 | 3 | $125,000 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| ElevateBio Technologies Inc. | 2 | $115,000 | 100.0% |
| ModernaTX, Inc. | 2 | $115,000 | 100.0% |
| CRISPR Therapeutics, Inc. | 1 | $125,000 | 100.0% |
| Dicerna Pharmaceuticals, Inc. | 1 | $120,000 | 0.0% |
| Sumitomo Pharma Oncology | 1 | $109,408 | 100.0% |